Ipsen S.A. publishes its 2022 Universal registration document
PRESS RELEASE Regulated Information Ipsen publishes its 2022 Universal Registration Document Paris , 6 April 2023 – Ipsen... | April 6, 2023
Source: marketscreener.com
Page 6 - Sponsored Level News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sponsored Level. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sponsored Level Today - Breaking & Trending Today
Investegate |Ipsen Pharma Announcements | Ipsen Pharma: Ipsen receives new FDA PDUFA date for investigational palovarotene for the treatment of people with FOP
Investegate announcements from Ipsen Pharma, Ipsen receives new FDA PDUFA date for investigational palovarotene for the treatment of people with FOP
Source: investegate.co.uk
Ipsen completes acquisition of Albireo, expanding the
Ipsen completes acquisition of Albireo, expanding the scope of its Rare Disease portfolio Bringing medicines to patients with rare liver...
Source: globenewswire.com
Investegate |Ipsen Pharma Announcements | Ipsen Pharma: Ipsen completes acquisition of Albireo, expanding the scope of its Rare Disease portfolio
Investegate announcements from Ipsen Pharma, Ipsen completes acquisition of Albireo, expanding the scope of its Rare Disease portfolio
Source: investegate.co.uk
Ipsen presents strong full-year 2022 results and guidance for 2023
2022 total sales up by 8.5% at CER1 (14.4% as reported) with growth platforms’2 sales increasing by 20.9%1 and Somatuline® (lanreotide) sales declining by 5.6%1
Source: einnews.com